Novocure Inc is a global oncology company that is dedicated to extending survival in aggressive forms of cancer through the development and commercialization of innovative therapies. With a focus on Tumor Treating Fields, their therapy has shown consistent anti-mitotic effects in preclinical and clinical research. They have ongoing or completed clinical trials in various types of cancer, including brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer.
Novocure is committed to corporate social responsibility and supporting independent organizations that share their goals of advancing medical care and improving patient outcomes. Their mission is centered around patients, and they strive to redefine living with cancer by collaborating with patients, caregivers, and advocacy partners. Founded in Haifa, Israel in 2000, Novocure has grown into a global oncology company with extensive experience in the oncology, biotechnology, and medical device industries.
Generated from the website
